Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  Sinovac: China Vaccine Sales Drop Due to New Government Policies
  OrbusNeich Launches Two Peripheral Artery Disease Devices
  PharmaBlock, a Nanjing CRO/CMO, to List on China's Third Board
  WuXi AppTec and Huawei Launch China Big Data Precision Medicine Project
  Shanghai's HighLight Capital Raising $229 Million for Healthcare Fund
  China's FDA Losing Experienced Staff to Private Companies
  Hengrui Medicine Signs MOU for China Rights to Oncolytic Virus Drug
  Ping An's China Mobile Health Site Raises $500 Million at $3 Billion Valuation
  China Cuts Prices on GSK, AstraZeneca and Beta Drugs by Up to Two-Thirds
  ViroMed of Korea Receives US Fast Track Status for Gene Therapy


ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors